Popular Articles

Conference: Discovery Partnerships: Academia & Industrial Interactions
Opal Events is proud to present our next exciting conference Drug Discovery Partnerships: Academia & Industrial Interactions , to be held at the Hyatt Regency in Boston on October 28-30, 2009.

Bioheart To Introduce Improved Heart Failure Monitoring Systems At Heart Failure Nurses Annual Meeting
Bioheart, Inc., (OTC Bulletin Board: BHRT) a company committed to delivering intelligent devices and biologics that help monitor, diagnose and treat heart failure and cardiovascular diseases announced that the company will be introducing its heart failure monitoring systems at the American Association of Heart Failure Nurses 5th Annual Meeting. This year"s meeting will take place from June 25 - 27, 2009 at the Hyatt Regency Minneapolis in Minneapolis, Minnesota.
News of the day
PolyMedix Receives United States Patent For Angiogenesis Inhibitor Compounds
PolyMedix, Inc. (OTCBB: PYMX), an emerging biotechnology company developing acute care products for infectious diseases and acute cardiovascular disorders, announced that the United States Patent and Trademark Office issued a patent assigned to PolyMedix relating to angiogenesis inhibitors. The patent, number 7,553,876, entitled "Polycationic Compounds and Uses Thereof," relates to therapeutic uses of PolyMedix compounds for inhibiting angiogenesis.
Mental Health

National Community Pharmacists Association's Statement On Medicare Part D Cost-Savings Plan

The nation"s drugmakers have pledged tens of billions of dollars to reduce seniors" out of pocket Medicare Part D drug costs, President Barack Obama announced today. In response, National Community Pharmacists Association (NCPA) Executive Vice President and CEO Bruce T. Roberts, RPh, issued the following statement: "We commend the White House, Congress and PhRMA for working to lower prescription drug costs for seniors, especially when dealing with the so-called Medicare Part D "donut-hole". Independent community pharmacies across the country are on the front lines keeping our seniors healthy by maximizing the safety and therapeutic value of their medications. We share the goal of lowering drug costs but want to learn more about this program to ensure community pharmacies are treated fairly and can continue serving patients. "Community pharmacies are the interface between Part D plans and Medicare beneficiaries. We spent countless hours mitigating the rocky transition when Medicare Part D launched in 2006 and we want to be sure this program has a smoother transition. As a result we will be reaching out to Congress and the White House to learn the answers to important questions pharmacies and our patients have, so that we can offer solutions that will improve the implementation process this time around. "For example, we want to know when the program will start, how the discounts will be calculated, who will pass them along, and how the pharmacist will receive full reimbursement for prescriptions that are dispensed. Community pharmacies must play an important role if health care reform and cost savings proposals such as this are going to be successful." The National Community Pharmacists Association


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):